Fact CheckerSign in

NCT07380451Recruiting

Modular Intervention for Depression Study

Modular Optimization of Psychotherapy for Individuals With Depression Complicated by Personality Dysfunction and Complex Trauma: A Pilot Study in the Chilean Public Health System

Source: ClinicalTrials.gov · Last updated 12 May 2026

Brief summary (registry, in English)

The goal of this psychotherapy clinical trial is to evaluate whether a algorithm-based personalized modular psychotherapy is more effective than usual individual psychotherapy in treating major depressive disorder complicated by personality dysfunction and/or complex trauma in adults aged 18 to 65 receiving care in the Chilean public mental health system. The main questions it aims to answer are: * Does algorithm-based modular psychotherapy lead to greater clinically significant reduction and remission of depressive symptoms compared to usual psychotherapy? * Does algorithm-based modular psychotherapy lead to greater improvement in emotional regulation, interpersonal functioning, and self-related functioning, including changes observed in daily life? Researchers will compare algorithm-based modular psychotherapy to usual individual psychotherapy provided in public community mental health centers to see if the modular, personalized approach results in better clinical outcomes, stronger therapeutic alliance, and higher treatment satisfaction. Participants will: * Be randomly assigned to receive either algorithm-based modular psychotherapy or usual individual psychotherapy * Attend weekly individual psychotherapy sessions * Complete structured diagnostic interviews and self-report questionnaires before, during, and after treatment * Provide brief daily reports on mood, emotions, and interpersonal experiences using a smartphone before and after treatment

Status (registry)
Recruiting
Study type
Interventional
Enrollment
150 (estimated)
First submitted
29 Dec 2025
Start date
1 May 2026
Primary completion date
31 Dec 2027
Lead sponsor
Pontificia Universidad Catolica de Chile
Diseases
Depression
NCT number
NCT07380451

What you commit to

  • Study type: Interventional
  • Planned participants: 150
  • From 1 May 2026 to the primary completion date, 31 Dec 2027
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Concurrent participation in another active psychotherapy or initiation/change of psychotropic medication during the study period, except for:
    • Stable antidepressant treatment
    • Medications prescribed for sleep
    • Benzodiazepines used only on an as-needed (PRN) basis.

Other illness

  • Any severe psychiatric disorder other than major depressive disorder that is the primary clinical diagnosis, including:
    • Schizophrenia or other psychotic disorders
    • Bipolar I disorder
  • Severe substance use disorder, active within the past 6 months.
  • Diagnosis of post-traumatic stress disorder (PTSD) meeting full diagnostic criteria, as assessed by standardized instruments (ITEM and ITQ).
  • Meeting diagnostic criteria for:
    • Antisocial personality disorder (two or more criteria), or
    • Borderline personality disorder with more than three diagnostic criteria
  • Severe medical, cognitive, or psychosocial condition that would interfere with participation in weekly psychotherapy.

Other

  • Acute suicide risk requiring immediate intensive intervention, as assessed by the MINI.
  • Inability to comply with study procedures or assessments.

Who the study is looking for

  • Current diagnosis of major depressive disorder, defined as:
    • Positive diagnosis on the MINI diagnostic interview, and
    • PHQ-9 score greater than 10
  • Evidence of personality dysfunction, defined as a score above the cutoff on the Level of Personality Functioning Scale-Brief Form (LPFS-BF 2.0).
  • History of moderate to severe early life adversity, defined as elevated scores on at least one scale of the Childhood Trauma Questionnaire (CTQ), and/or clinically significant alterations in self-organization.
  • Presence of at least one elevated domain of alteration of self-organization, including emotion regulation difficulties, interpersonal sensitivity, and/or interpersonal functioning problems, as assessed by standardized self-report measures (DERS, A-RSQ, OQ-45-IR).
  • Receiving care at a participating public community mental health center in Chile.
  • Ownership of a smartphone (Android or iOS) with internet access and an active data plan.
  • Ability to provide written informed consent.

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
COSAM La Bandera
Coordinator of this site? Confirm its status
SantiagoChileActive, not recruiting
COSAM Rinconada
Coordinator of this site? Confirm its status
SantiagoChileRecruiting
COSAM La Pintana
Coordinator of this site? Confirm its status
SantiagoChileRecruiting
COSAM La Granja
Coordinator of this site? Confirm its status
SantiagoChileRecruiting
CDT CASR
Coordinator of this site? Confirm its status
SantiagoChileRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.